GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding GeoVax Labs, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 397.5K | 458.4K | +60.9K (+15.3%) |
| Value | $1.99M | $1.98M | −$7.00K (−0.4%) |
New holders (4)
Institutions that held GeoVax Labs, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 41,141 | $178.0K | 0.02% |
| Squarepoint Ops LLC | 11,706 | $51.0K | 0.00% |
| Two Sigma Securities, LLC | 11,383 | $49.0K | 0.01% |
| UBS Group AG | 1,817 | $8.00K | 0.00% |
Sold out (1)
Institutions that held GeoVax Labs, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Citadel Advisors LLC | 14,908 | $75.0K |